Literature DB >> 11909812

Brain angiotensin II: new insights into its role in sympathetic regulation.

Irving H Zucker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909812     DOI: 10.1161/01.res.0000014287.96335.21

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  17 in total

1.  Spinophilin regulates central angiotensin II-mediated effect on blood pressure.

Authors:  Andrey C da Costa Goncalves; Marco Antonio Peliky Fontes; Enno Klussmann; Fatimunnisa Qadri; Jürgen Janke; Maik Gollasch; Johanna Schleifenbaum; Dominik Müller; Jens Jordan; Jens Tank; Friedrich C Luft; Volkmar Gross
Journal:  J Mol Med (Berl)       Date:  2011-08-05       Impact factor: 4.599

2.  Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea.

Authors:  Ana Quenia Gomes da Silva; Marco Antônio Peliky Fontes; Nancy Lapp Kanagy
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 3.  Obstructive sleep apnea and hypertension: mechanisms, evaluation, and management.

Authors:  John M Dopp; Kevin J Reichmuth; Barbara J Morgan
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

4.  Genetic variants in the renin-angiotensin system and blood pressure reactions to the cold pressor test.

Authors:  Laiyuan Wang; Liping Hou; Hongfan Li; Jing Chen; Tanika N Kelly; Cashell E Jaquish; Dabeeru C Rao; James E Hixson; Dongsheng Hu; Chung-Shiuan Chen; Charles Gu; Shufeng Chen; Xiangfeng Lu; Paul K Whelton; Jiang He; Fanghong Lu; Jianfeng Huang; De-Pei Liu; Dongfeng Gu
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

Review 5.  Molecular mechanisms of chronic intermittent hypoxia and hypertension.

Authors:  Jag Sunderram; Ioannis P Androulakis
Journal:  Crit Rev Biomed Eng       Date:  2012

Review 6.  Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults.

Authors:  John M Dopp; Barbara J Morgan
Journal:  Sleep Breath       Date:  2010-06-28       Impact factor: 2.816

7.  Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; June Glover; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-09       Impact factor: 4.733

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.

Authors:  Julian M Stewart; Anthony J Ocon; Debbie Clarke; Indu Taneja; Marvin S Medow
Journal:  Hypertension       Date:  2009-03-16       Impact factor: 10.190

10.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.